+3.1%
BSX vs MRNA
-27.3%
+30.4%
-61.5%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 5y.
| Period | Portfolio | MRNA | Excess | Alpha |
|---|---|---|---|---|
| 1D | -2.3% | -2.2% | -0.2% | -2.3% |
| 7D | -5.3% | -12.7% | +7.4% | -5.0% |
| 30D | -5.7% | -20.7% | +15.0% | -5.2% |
| 3M | -15.0% | +46.3% | -61.2% | -16.1% |
| 6M | -25.9% | +305.2% | -331.2% | -30.5% |
| YTD | -56.0% | +561.2% | -617.2% | -59.7% |
| 1Y | -56.5% | +772.1% | -828.6% | -60.8% |
| 3Y | -22.9% | +147.0% | -169.9% | -28.4% |
| All | +3.1% | -27.3% | +30.4% | -7.5% |
Cumulative growth
Daily Returns
Daily percentage return beside MRNA.
Daily Out/Under-Performance
Portfolio return minus MRNA return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 5y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
5y analysis · Full analysis span regression · 6 months rolling